These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3224164)

  • 21. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
    Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
    Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
    Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM
    Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of cyanamide in fasted and unfasted rats.
    Obach R; Valenti C; Valles J; Valles JM; Domenech J
    Biopharm Drug Dispos; 1986; 7(3):273-80. PubMed ID: 3730527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinium myrtillus anthocyanosides pharmacokinetics in rats.
    Morazzoni P; Livio S; Scilingo A; Malandrino S
    Arzneimittelforschung; 1991 Feb; 41(2):128-31. PubMed ID: 2043174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of (-)-carbovir in rats. Evidence for nonlinear elimination.
    Brouwer KR; St Claire RL; Lagarde J; Patanella JE; Walsh JS; Miwa GT
    Drug Metab Dispos; 1990; 18(6):1078-83. PubMed ID: 1981516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Des-enkephalin-gamma-endorphin: bioavailability in rats following the subcutaneous and intramuscular route of administration.
    Verhoef JC; van den Wildenberg HM
    Regul Pept; 1986 Apr; 14(2):113-24. PubMed ID: 3715065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats.
    Konsue N; Kirkpatrick J; Kuhnert N; King LJ; Ioannides C
    Mol Nutr Food Res; 2010 Mar; 54(3):426-32. PubMed ID: 19866468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interspecies comparison of pharmacokinetic profile and bioavailability of (+/-)-gossypol in male Fischer-344 rats and male B6C3F mice.
    Abou-Donia MB; Othman MA; Obih P
    Toxicology; 1989 Apr; 55(1-2):37-51. PubMed ID: 2711405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic profile of (+/-)-gossypol in male Sprague-Dawley rats following single intravenous and oral and subchronic oral administration.
    Othman MA; Abou-Donia MB
    Proc Soc Exp Biol Med; 1988 May; 188(1):17-22. PubMed ID: 3368474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of dietary phenethyl isothiocyanate in rats.
    Ji Y; Kuo Y; Morris ME
    Pharm Res; 2005 Oct; 22(10):1658-66. PubMed ID: 16180123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low oral bioavailability and pharmacokinetics of senkyunolide a, a major bioactive component in Rhizoma Chuanxiong, in the rat.
    Yan R; Lin G; Ko NL; Tam YK
    Ther Drug Monit; 2007 Feb; 29(1):49-56. PubMed ID: 17304150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of triflusal and its main metabolite in rats and dogs.
    Ramis J; Mis R; Forn J
    Eur J Drug Metab Pharmacokinet; 1991; 16(4):261-8. PubMed ID: 1823869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of ethylene glycol. III. Plasma disposition and metabolic fate after single increasing intravenous, peroral, or percutaneous doses in the male Sprague-Dawley rat.
    Frantz SW; Beskitt JL; Tallant MJ; Zourelias LA; Ballantyne B
    Xenobiotica; 1996 May; 26(5):515-39. PubMed ID: 8736063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and bioavailability of midazolam in man.
    Heizmann P; Eckert M; Ziegler WH
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):43S-49S. PubMed ID: 6138080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of HI-6 oxime in rats after intravenous and intramuscular administration.
    Simons KJ; Briggs CJ
    J Pharm Pharmacol; 1985 May; 37(5):367-9. PubMed ID: 2862253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of correlation between pharmacokinetic and pharmacodynamic behaviour of cyanamide in man. A preliminary report.
    Obach R; Pruñonosa J; Torrent J; Colom H; Peraire C; Izquierdo I; Domenech J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():185-90. PubMed ID: 1820876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.